1. Introduction
===============

2-Amino-1,3,4-thiadiazole derivatives are well known as compounds of a wide range of anticancer activity \[[@B1-molecules-16-05496],[@B2-molecules-16-05496],[@B3-molecules-16-05496],[@B4-molecules-16-05496]\] that have been prepared from their respective aldehydes \[[@B5-molecules-16-05496]\] or carboxylic acids \[[@B6-molecules-16-05496]\]. They appeared to be the most feasible route to fused imidazo\[2,1-*b*\]-1,3,4-thiadiazole rings \[[@B6-molecules-16-05496],[@B7-molecules-16-05496],[@B8-molecules-16-05496],[@B9-molecules-16-05496],[@B10-molecules-16-05496],[@B11-molecules-16-05496],[@B12-molecules-16-05496],[@B13-molecules-16-05496],[@B14-molecules-16-05496]\] of interesting potential applications \[[@B15-molecules-16-05496],[@B16-molecules-16-05496]\]. Some of these compounds show anticancer \[[@B17-molecules-16-05496]\], antitubercular \[[@B18-molecules-16-05496]\], antibacterial \[[@B19-molecules-16-05496]\], antifungal \[[@B20-molecules-16-05496]\], anticonvulsant analgesic \[[@B21-molecules-16-05496]\], antisercetory \[[@B22-molecules-16-05496]\] and antiapoptotic \[[@B23-molecules-16-05496]\] properties. Also, certain compounds incorporating the imidazo\[2,1-*b*\]-1,3,4-thiadiazole moiety are used as anti-inflammatory \[[@B24-molecules-16-05496]\], cardiotonic \[[@B25-molecules-16-05496]\], diuretic \[[@B26-molecules-16-05496]\] and herbicidal \[[@B27-molecules-16-05496]\] agents and are used in the manufacture of dyes \[[@B28-molecules-16-05496],[@B29-molecules-16-05496],[@B30-molecules-16-05496]\]. With all this in mind, the present paper focused on the synthesis of some new fused imidazo\[2,1-*b*\]-1,3,4-thiadiazole rings and testing their reactivity towards electrophilic substitution reactions and against *Staphylococcus aureus, Candida albicans, Pseudomonas aeruginosa*and *Escherichia coli*.

2. Results and Discussion
=========================

2-Aryl-2*H*-1,2,3-triazole-4-carboxylic acids **1** \[[@B31-molecules-16-05496]\] were chosen as starting materials for these studies. They were converted with thiosemicarbazide in the presence of POCl~3~ to the corresponding 2-amino-5-(2-aryl-2*H*-1,2,3-triazol-4-yl)-1,3,4-thiadiazoles **2-4** in good yields ([Scheme 1](#molecules-16-05496-f002){ref-type="fig"}).

![Synthesis and electrophilic substitution reactions of imidazo\[2,1-b\]-1,3,4-thiadiazoles.](molecules-16-05496-g002){#molecules-16-05496-f002}

The structures of the above compounds were confirmed from their spectral data. Their IR spectra showed two medium intensity bands at range 3282--3485 and 3165--3300 cm^−1^ due to the asymmetric and symmetric NH stretching frequencies of the primary amino group \[[@B32-molecules-16-05496],[@B33-molecules-16-05496]\].
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###### 

Infrared and ^1^H NMR spectral data of imidazo\[2,1-*b*\]-1,3,4-thiadiazoles (5-7).

  Cpd. No.   IR (cm^−1^)   ^1^H-NMR Chemical Shift (δ/ppm) \*                                                 
  ---------- ------------- ------------------------------------ ------ ------ ----- ------------------ ------ ------
  **5a**     1638          1594                                 1534   1490   690   7.33--8.14 (10H)   8.07   8.33
  **5b**     1635          1595                                 1532   1490   669   7.61--8.84 (9H)    7.50   8.46
  **5c**     1634          1594                                 1536   1490   669                             
  **5d**     1629          1527                                 1540   1844   690                             
  **5e**     1631          1555                                 1528   1488   669                             
  **5f**     1626          1600                                 1529   1488   669   7.42--8.11 (8H)    8.06   8.50
  **5g**     1651          1601                                 1538   1486   690                             
  **5h**     1649          1565                                 1533   1487   671                             
  **5i**     1652          1599                                 1533   1485   670                             
  **6a**     1640          1597                                 1545   1489   662   7.25--8.14 (10H)          8.41
  **6b**     1641          1594                                 1522   1487   669   7.44--8.15 (9H)           8.42
  **6c**     1637          1595                                 1524   1488   669   7.42--8.14 (9H)           8.41
  **6d**     1632          1549                                 1526   1436   686   7.35--8.06 (9H)           8.42
  **6e**     1632          1552                                 1522   1486   669   7.57--8.03 (8H)           8.42
  **6f**     1628          1545                                 1521   1686   669   7.42--8.04 (8H)           8.42
  **6g**     1645          1550                                 1510   1488   686   7.36--8.10 (9H)           8.42
  **6h**     1642          1568                                 1519   1487   672   7.49--8.09 (8H)           8.41
  **6i**     1641          1585                                 1522   1488   672   7.42--8.09 (8H)           8.41
  **7a**     1634          1595                                 1532   1488   663   7.37--8.15 (10H)          8.43
  **7b**     1640          1594                                 1527   1489   668   7.42--8.14 (9H)           8.41
  **7c**     1636          1596                                 1530   1489   669   7.43--8.14 (9H)           8.41
  **7d**     1642          1547                                 1522   1486   685                             
  **7e**     1633          1565                                 1535   1485   671   7.58--8.03 (8H)           8.41
  **7f**     1633          1565                                 1521   1487   671   7.43--8.03 (8H)           8.42
  **7g**     1639          1545                                 1509   1488   685   7.39--8.11 (9H)           8.42
  **7h**     1640          1595                                 1555   1487   669   7.49--8.09 (8H)           8.41
  **7i**     1639          1598                                 1565   1486   670   7.43--8.10 (8H)           8.41

\*s = Singlet, m = multiplet.

Also, the ^1^H-NMR spectra revealed a singlet at δ 7.60--7.61 (2H) for exchangeable NH~2~ protons and a singlet at δ 8.51--8.52 for the H-5 triazole proton. The structures were further confirmed from mass spectral data (cf. Experimental). The reaction of 2-amino-5-(2-aryl-2*H*-1,2,3-triazol-4-yl)-1,3,4-thiadiazoles **2-4** with phenacyl(*p*-substituted phenacyl) bromides in boiling dry ethanol led to the formation of the new series of 6-aryl-2-(2-aryl-2*H*-1,2,3-triazol-4-yl)imidazo\[2,1-*b*\]-1,3,4-thiadiazoles **5a-i**. The reaction proceeds via the formation of the iminothiadiazole intermediate, followed by dehydrative cyclization to form the desired fused heterocycle \[[@B19-molecules-16-05496]\]. The disappearance of the NH~2~ absorption bands in the IR spectra of **5** as well as the absence of the exchangeable singlets of this group in their ^1^H-NMR spectra, in addition to the presence of singlets at δ 8.33--8.50 for triazole protons, and a singlet at δ 7.50--8.07 for imidazole protons confirmed the structures ([Table 1](#molecules-16-05496-t001){ref-type="table"}). It was reported that \[[@B27-molecules-16-05496],[@B28-molecules-16-05496],[@B29-molecules-16-05496]\] the electrophilic substitution reactions of imidazo\[2,1-*b*\]-1,3,4-thiadiazole take place at position 5. Thus, in the present work, bromination of **5** with bromine as well as iodination with iodine monochloride gave the respective 5-bromo (**6a-i**) and 5-iodo derivatives **7a-i**. The ^1^H-NMR spectra of both derivatives revealed the disappearance of H-5 singlet of imidazole ring and presence of triazole proton as singlets at δ 8.41--8.43 ([Table 1](#molecules-16-05496-t001){ref-type="table"}). The structure of the imidazothiadiazoles **5-7** was further confirmed by studying their mass spectral data, where the possible fragmentation pathways for all compounds gave rise to the bicyclic (I), 2-aryl-4-cyano-1,2,3-triazole (II). In addition to 2-acetylenic imidazo-thiadiazoles (III) ([Figure 1](#molecules-16-05496-f001){ref-type="fig"}). The relative intensity of the molecular ion peaks and the most prominent peaks are listed in ([Table 2](#molecules-16-05496-t002){ref-type="table"}).

![The most prominent fragments of the mass spectra of imidazo\[2,1-*b*\]-1,3,4-thiadiazoles.](molecules-16-05496-g001){#molecules-16-05496-f001}
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###### 

Relative intensity of the molecular ion peaks and the most prominent peaks in the mass spectra of imidazo\[2,1-*b*\]-1,3,4-thiadiazoles (5-7).

  Cpd. No.   M        I       II      III
  ---------- -------- ------- ------- -----
  **5a**     33       2       11      8
  **5b**     100,78   10      70      5
  **5g**     21       5       36      4
  **5i**     29       24      40      4
  **6a**     69       100     34      18
  **6d**     7        57      100     12
  **6f**     8        40      8       7
  **6g**     22       100     29      19
  **6i**     5        35      34      1
  **7a**     100      73      22      18
  **7e**     39       16,15   44,46   2
  **7g**     46       100     18      57
  **7i**     14       36      18      1

Formylation of **5a** with dimethylformamide in the presence of phosphorus oxychloride (Vilsmeier-Haack reagent) gave the 5-formyl derivative **8** in excellent yield. Its IR spectrum showed a strong absorption band at 1676 cm^−1^ characteristic of the entered carbonyl group and two weak absorption bands at 2921 and 2885 cm^−1^ of formyl hydrogen. Also, the ^1^H-NMR spectrum revealed the absence of the H-5 singlet of the imidazole ring and exhibited two singlets at δ 8.53 and 10.10 for the triazole and formyl protons respectively.

Biological screening: antimicrobial activity tests
--------------------------------------------------

The antibacterial activities of compounds **2-8** were tested against the micro-organisms *Staphylococcus aureus (ATCC6538p), Candida albicans (ATCC2091), Pseudomonas aeruginosa (ATCC9027)*and *Escherichia coli*(ATCC8739). After incubation, the diameters of inhibition zones around the wells were measured, to the nearest mm, in three different directions using a ruler and the average diameter was recorded and compared to that of the control. From the data presented in [Table 3](#molecules-16-05496-t003){ref-type="table"} it is clear that compounds **5d** and **6h** were moderately active against *Escherischia coli,*while **7b** was also moderately active but against *Pseudomonas aeruginosa* microorganisms. Generally, other derivatives were slightly too moderately active against *Candida albicans*, *Pseudomonas aeruginosa* and *Escherischia coli*. Finally, compounds **2--8** were found to be inactive against *Staphylococcus aureus*.
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###### 

Result of antimicrobial activity tests (agar diffusion method) of compounds (2--8).

  Test microorganisms   *S*   *C*   *Ps*   *E*
  --------------------- ----- ----- ------ -----
  **Imepenam**          30    \-    30     26
  **Ampicillin**        30    \-    \-     \-
  **Clotrimazole**      \-    40    \-     \-
  **2**                 \-    18    22     17
  **3**                 \-    18    22     16
  **4**                 \-    18    22     16
  **5a**                \-    18    22     17
  **5b**                \-    18    22     18
  **5c**                \-    18    22     16
  **5d**                \-    18    22     20
  **5e**                \-    18    22     16
  **5f**                \-    18    22     18
  **5g**                \-    18    22     16
  **5h**                \-    19    22     18
  **5i**                \-    18    23     16
  **6a**                \-    19    22     17
  **6b**                \-    18    23     16
  **6c**                \-    18    22     17
  **6d**                \-    18    23     17
  **6e**                \-    18    22     16
  **6f**                \-    18    22     17
  **6g**                \-    18    22     17
  **6h**                \-    18    22     20
  **6i**                \-    18    22     16
  **7a**                \-    18    22     19
  **7b**                \-    18    26     19
  **7c**                \-    18    22     16
  **7d**                \-    18    22     16
  **7e**                \-    19    22     17
  **7f**                \-    19    22     17
  **7g**                \-    19    22     16
  **7h**                \-    18    22     17
  **7i**                \-    18    22     16
  **8**                 \-    18    22     19
  **DMF**               \-    18    22     16

*S:* *Staphylococcus aureus; C: Candida albicans; Ps: Pseudomonas aeruginosa; E: Escherichia coli.*

3. Experimental
===============

3.1. General
------------

Melting points were determined on a Kofler Block and are uncorrected. TLC was done on Merck Kiesel gel 60-f 254 precoated plastic plates. Infrared spectra (IR) were measured with a Fourier Transform Infrared 8400 spectrophotometer (BRUKER TENSOR 37) using potassium bromide pellets. The ^1^H-NMR spectra were recorded on a JEOL JNM ECA 500 MHZ with tetramethylsilane as internal standard. Mass spectra (MS) were recorded at 70 ev using GCMS-QP 1000EX mass spectrometer. Microanalyses were performed by the Microanalytical Unit, Cairo University, Cairo. 2-Aryl-2H-1,2,3-triazole-4-carboxylic acids **1** were prepared from the respective D-glucose arylosotriazoles as described earlier \[[@B31-molecules-16-05496]\].

### 3.2.1. 2-Amino-5-(2-aryl-2H-1,2,3-triazol-4-yl)-1,3,4-thiadiazoles **(2-4)**

2-Aryl-2*H*-1,2,3-triazole-4carboxylic acids (**1**, 0.1 mol) and thiosemicarbazide (9.1 g, 0.1 mol) were refluxed gently in the presence of phosphorus oxychloride (30 mL) for 45 min. The reaction mixture was cooled and quenched with cold water (90 mL). The resulting solution was refluxed for an additional 6 hours. The separated solid was filtered and suspended in water and basified with potassium hydroxide. The solid was filtered, washed with water, dried and crystallized from a suitable solvent.

*2-Amino-5-(2-phenyl-2H-1,2,3-triazol-4-yl)-1,3,4-thiadiazole* (**2**). Yield (75%); m.p. 251--252 °C (crystallization from ethanol); IR (cm^−1^): 3282, 3165 (NH~2~), 1637 (thiadiazole ring C=N), 1555 (triazole ring C=N) and 690 (thiadiazole ring C-S-C); ^1^H-NMR (DMSO-d~6~, δ, ppm): 7.42 (t, 1H, aromatic-H), 7.55 (t, 2H, aromatic-H), 7.60 (s, 2H, exchangeable NH~2~), 7.98 (d, 2H, aromatic-H) and 8.51 (s, 1H, triazole-H); MS, *m/z* (%): 244 (100, M+), 188 (23, M+-C~2~H~2~N~3~), 161 (3, M+-C~2~H~3~N~4~), 145 (2, M+-C~2~HN~3~S), 105 (3, M+-C~4~H~3~N~4~S) and 91 (21, M+-C~2~H~3~N~5~S); Anal. Calc. for C~10~H~8~N~6~S (244.28): C, 49.17; H, 3.30; N, 34.40%, found: C, 49.00; H, 3.45; N, 34.25%.

*2-Amino-5-\[2-(4-bromophenyl)-2H-1,2,3-triazol-4-yl\]-1,3,4-thiadiazole* (**3**). Yield (77%); m.p. 259--260 °C (crystallization from dioxane); IR (cm^−1^): 3485, 3300 (NH~2~), 1639 (thiadiazole ring C=N), 1597 (triazole ring C=N) and 660 (thiadiazole ring C-S-C); ^1^H-NMR (DMSO-d~6~δ, ppm): 7.55 (d, 2H, aromatic-H), 7.61 (s,2H, exchangeable NH~2~), 7.98 (d, 2H, aromatic-H) and 8.52 (s, 1H, triazole-H); MS, *m/z* (%): 324 (8, M+ +2), 322 (5, M+), 266 (3, M+-CH~2~N~3~), 239 (1, M+-C~2~H~3~N~4~), 244 (100, M+-Br+H), 188 (54, M+-CHBrN~3~), 184 (3, M+-C~4~H~2~N~4~S), 169 (4, M+-C~4~H~3~N~5~S),161 (1, M+-C~2~H~2~BrN~4~), 145 (1, M+-C~2~BrN~3~S), 133 (2, M+-C~3~BrN~3~S), 105 (4, M+-C~4~H~2~BrN~4~S) and 91 (9, M+-C~2~HBrN~5~S); Anal. Calc. for C~10~H~7~BrN~6~S (323.17): C, 37.17; H, 2.18; N, 26.00%, found. C, 37.00; H, 2.60; N, 25.70%.

*2-Amino-5-\[2-(4-chlorophenyl)-2H-1,2,3-triazol-4-yl\]-1,3,4-thiadiazole* (**4**). Yield (65%); m.p. 269--270 °C (crystallization from dioxane); IR (cm^−1^): 3465, 3290 (NH~2~), 1626 (thiadiazole C=N), 1532 (triazole C=N) and 694 (thiadiazole C-S-C); Anal. Calc. for C~10~H~7~ClN~6~S (278.72): C, 43.09; H, 2.53; N, 30.15%, found. C, 43.12; H, 2.51; N, 30.17%.

### 3.2.2. 6-Aryl-2-(2-aryl-2H-1,2,3-triazol-4-yl)imidazo\[2,1-b\]-1,3,4-thiadiazoles **5a-i**

A mixture of equimolar quantities of thiadiazoles **2-4** (0.01 mol) and phenacyl (*p*-substituted phenacyl) bromides (0.01 mol) was refluxed in dry ethanol (50 mL) for 24 hours. The excess of solvent was distilled off and the solid hydrobromide salt that separated out was collected by filtration, suspended in water and neutralized by sodium carbonate to get free base **5a-i**. The product was filtered, washed with water, dried and crystallized from carbon tetrachloride. Their IR, ^1^H-NMR spectra and analytical data are listed in [Table 1](#molecules-16-05496-t001){ref-type="table"} and [Table 4](#molecules-16-05496-t004){ref-type="table"}.

### 3.2.3. 6-Aryl-2-(2-aryl-2H-1,2,3-triazol-4-yl)-5-haloimidazo\[2,1-b\]-1,3,4-thiadiazoles **6a-i** and **7a-i**

A solution of bromine (iodine monochloride) (0.01 mol) in acetic acid (10 mL) was gradually added to a suspension of **5a-i** (0.01 mol) in acetic acid (10 mL) with stirring for one to eight days at room temperature. The reaction mixture was poured onto ice cold water. The separated solid was collected, washed with water, dried and crystallized from either chloroform or benzene in methanol mixture. Their IR, ^1^H-NMR spectra and analytical data are listed in [Table 1](#molecules-16-05496-t001){ref-type="table"} and [Table 4](#molecules-16-05496-t004){ref-type="table"}.
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###### 

Analytical data of imidazo\[2,1-*b*\]-1,3,4-thiadiazoles (**5-7**).

  Cpd. No.   Mp (°C)   Yield (%)   Formula                  Calcd. %   Found %                          
  ---------- --------- ----------- ------------------------ ---------- --------- ------- ------- ------ -------
  **5a**     225-226   60          C~18~H~12~N~6~S          62.77      3.51      24.40   62.50   3.42   24.43
  **5b**     253-254   62          C~18~H~11~BrN~6~S        51.07      2.62      19.85   51.00   2.32   19.92
  **5c**     257-258   61          C~18~H~11~ClN~6~S        57.07      2.93      22.18   57.11   2.86   22.20
  **5d**     285-286   61          C~18~H~11~BrN~6~S        51.07      2.62      19.85   51.15   2.40   20.06
  **5e**     281-282   60          C~18~H~10~ Br~2~N~6~S    43.05      2.01      16.73   43.07   2.00   16.81
  **5f**     276-277   66          C~18~H~10~BrClN~6~S      47.23      2.20      18.36   47.31   2.12   18.02
  **5g**     279-280   58          C~18~H~11~ClN~6~S        57.07      2.93      22.18   57.10   2.92   22.21
  **5h**     267-268   55          C~18~H~10~BrClN~6~S      47.23      2.20      18.36   47.19   2.26   18.41
  **5i**     271-272   58          C~18~H~10~ Cl~2~N~6~S    52.31      2.44      20.33   52.40   2.40   20.21
  **6a**     221-222   80          C~18~H~11~BrN~6~S        51.07      2.62      19.85   51.12   2.42   20.03
  **6b**     261-262   80          C~18~H~10~ Br~2~N~6~S    43.05      2.01      16.73   43.12   2.00   16.92
  **6c**     255-256   80          C~18~H~10~BrClN~6~S      47.23      2.20      18.36   47.21   2.15   18.38
  **6d**     265-266   82          C~18~H~10~ Br~2~N~6~S    43.05      2.01      16.73   43.05   2.01   16.73
  **6e**     246-247   76          C~18~H~9~ Br~3~N~6~S     37.21      1.56      14.46   37.22   1.81   14.51
  **6f**     248-249   80          C~18~H~9~Br~2~ClN~6~S    40.29      1.69      15.66   40.01   1.81   15.62
  **6g**     257-258   80          C~18~H~10~BrClN~6~S      47.23      2.20      18.36   47.12   2.25   18.39
  **6h**     259-260   80          C~18~H~9~Br~2~ClN~6~S    0.29       1.69      15.66   40.42   1.72   15.52
  **6i**     237-238   80          C~18~H~9~ BrCl~2~N~6~S   43.93      1.84      17.08   43.90   1.87   16.90
  **7a**     270-271   85          C~18~H~11~IN~6~S         45.97      2.36      17.87   45.82   2.39   17.85
  **7b**     251-252   83          C~18~H~10~BrIN~6~S       39.37      1.84      15.30   39.40   1.90   15.21
  **7c**     251-252   82          C~18~H~10~ClIN~6~S       42.83      2.00      16.65   42.90   2.03   16.82
  **7d**     273-274   85          C~18~H~10~BrIN~6~S       39.37      1.84      15.30   39.21   1.61   15.42
  **7e**     251-252   80          C~18~H~9~Br~2~IN~6~S     34.42      1.44      13.38   34.50   1.49   13.42
  **7f**     243-244   85          C~18~H~9~BrClIN~6~S      37.04      1.55      14.40   37.24   1.52   14.43
  **7g**     285-286   82          C~18~H~10~ClIN~6~S       42.83      2.00      16.65   42.72   1.95   16.62
  **7h**     255-256   84          C~18~H~9~BrClIN~6~S      37.04      1.55      14.40   36.92   1.61   14.41
  **7i**     253-254   80          C~18~H~9~Cl~2~IN~6~S     40.10      1.68      15.59   40.20   1.72   15.51

### 3.2.4. 5-Formyl-6-phenyl-2-(2-phenyl-2H-1,2,3-triazol-4-yl)imidazo\[2,1-*b*\]-1,3,4-thiadiazole **(8)**

The Vilsmeir-Haack reagent was prepared by adding phosphorus oxychloride (3 mL) to dimethyl-formamide (20 mL) at 0 °C with stirring. Then, compound **5a**(3.44 g, 0.01 mol) was added to the reagent and stirred at 0 °C for 30 min. The mixture was further stirred at room temperature for 2 hours and then at 60 °C for an additional 2 hours. The reaction mixture was then poured onto sodium carbonate solution and stirred at 90 °C for 2 hours. After cooling, the mixture was diluted with water and extracted with chloroform. The chloroform layer was washed with water, dried over anhydrous sodium sulfate and the residue obtained after removal of the solvent was crystallized from chloroform/ methanol. Yield (80%); m.p. 184--185 °C; IR (cm^−1^): 2921, 2885 (formyl hydrogen), 1676 (CO), 1629 (thiadiazole C=N), 1589 (imidazole C=N), 1492 (triazole C=N), 1444 (imidazole C=C) and 664 (thiadiazole C-S-C); ^1^H-NMR (CDCl~3,~δ, ppm): 7.44 (t, 1H, aromatic-H), 7.54 (m, 5H, aromatic-H), 7.89 (d, 2H, aromatic-H), 8.15 (d, 2H, aromatic-H), 8.53 (s, 1H, triazole-H) and 10.1 (s, 1H, formyl-H); Anal. Calc. for C~19~H~12~N~6~OS (372.40): C, 61.28; H, 3.25; N, 22.57%, found. C, 61.30; H, 3.30; N, 22.57%.

3.3. Antibacterial Activity Tests
---------------------------------

The antibacterial activity tests were performed according to agar diffusion method \[[@B34-molecules-16-05496]\] using ampicillin, imepenam and clotrimazole as the reference compounds. The Sterile cotton swabs were separately dipped into each of the adjusted organism cultures and excess inoculum was removed by pressing and rotating the swab firmly several times against the wall of the tube above the level of the liquid. The swab was streaked all over the surface of the nutrient agar in three dimensions at an angle of 60° to obtain an even distribution of the inoculum. The plates were then left to dry at room temperature for few minutes. A sterile cork porer (8 mm in diameter) is used to make wells in the solid nutrient agar plates, so that the distance between the edges of each two wells is not less than 24 mm. Fill each well with 75 μL of the test compound and another well with same volume of DMF as a vehicle control. Allow a period of free diffusion for 2 h, then incubated at 37 °C for 18--24 h.

4. Conclusions
==============

In conclusion, formation of diverse 2-amino-5-substituted-1,3,4-thiadiazoles using carbohydrates as precursors was successfully achieved, followed by their conversion into the novel target imidazo\[2,1-*b*\]-1,3,4-thiadiazole fused heterocyles. The antibacterial activities of the synthesized compounds were also examined.

*Sample Availability*: Samples of the compounds (**1-8**) are available from the authors.
